SEEGENE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21,900 KRW | 0.00% |
|
+2.10% | -4.37% |
| Mar. 14 | Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 24 | Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 796,654 | 5,016,451 | 3,145,564 | 1,352,594 | 1,063,631 | 1,008,365 | - |
| Enterprise Value (EV) 1 | 796,608 | 5,016,225 | 3,145,250 | 1,352,191 | 1,063,631 | 1,008,365 | 1,008,365 |
| P/E ratio | 29.9 x | 9.99 x | 5.89 x | 7.59 x | 1,636 x | 66.4 x | 23.5 x |
| Yield | 0.33% | 0.39% | 1.64% | 2.94% | - | - | - |
| Capitalization / Revenue | 6.53 x | 4.46 x | 2.3 x | 1.58 x | 2.9 x | 2.54 x | 2.19 x |
| EV / Revenue | 6.53 x | 4.46 x | 2.3 x | 1.58 x | 2.9 x | 2.54 x | 2.19 x |
| EV / EBITDA | 25,522,779,541 x | 7,242,031,777 x | 4,477,232,441 x | 5,316,059,368 x | - | - | - |
| EV / FCF | 34,523,630 x | 23,987,391 x | 11,548,969 x | 5,288,824 x | - | - | - |
| FCF Yield | 0% | 0% | 0% | 0% | - | - | - |
| Price to Book | 5.22 x | 7.77 x | 1.47 x | 1.18 x | - | 1.13 x | 1.12 x |
| Nbr of stocks (in thousands) | 51,984 | 51,984 | 51,567 | 49,728 | 46,447 | 46,044 | - |
| Reference price 2 | 15,325 | 96,500 | 61,000 | 27,200 | 22,900 | 21,900 | 21,900 |
| Announcement Date | 2/26/20 | 2/18/21 | 2/17/22 | 2/17/23 | 2/16/24 | - | - |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 122 | 1,125 | 1,370 | 853.4 | 367.4 | 397 | 460.2 |
| EBITDA | 31.21 | 692.7 | 702.6 | 254.4 | - | - | - |
| EBIT 1 | 22.42 | 676.2 | 666.7 | 195.9 | - | 12.2 | 50.7 |
| Operating Margin | 18.39% | 60.11% | 48.66% | 22.96% | - | 3.07% | 11.02% |
| Earnings before Tax (EBT) | 27.7 | 669.1 | 689.2 | 225.6 | - | - | - |
| Net income 1 | 26.67 | 502.3 | 536.6 | 182.1 | 0.448 | 17.2 | 48.7 |
| Net margin | 21.87% | 44.65% | 39.16% | 21.34% | 0.12% | 4.33% | 10.58% |
| EPS 2 | 513.0 | 9,662 | 10,359 | 3,586 | 14.00 | 330.0 | 933.0 |
| Free Cash Flow | 23,076 | 209,129 | 272,368 | 255,746 | - | - | - |
| FCF margin | 18,921.68% | 18,589.21% | 19,880.84% | 29,968.1% | - | - | - |
| FCF Conversion (EBITDA) | 73,928.44% | 30,190.99% | 38,767.38% | 100,514.96% | - | - | - |
| FCF Conversion (Net income) | 86,516.03% | 41,635.79% | 50,761.9% | 140,412.68% | - | - | - |
| Dividend per Share | 50.00 | 375.0 | 1,000 | 800.0 | - | - | - |
| Announcement Date | 2/26/20 | 2/18/21 | 2/17/22 | 2/17/23 | 2/16/24 | - | - |
1KRW in Billions2KRW
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 305.3 | 410 | 451.5 | 128.4 | 150.8 | 122.7 | 90.05 | 84.93 | 91.89 | 100.5 | 95.9 | 94.2 | 102.4 | 108.6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 128.6 | 200 | 199.7 | 13 | -32.24 | 15.52 | -13.77 | -9.663 | -10.09 | 3.477 | 0.1 | 0.9 | 3.3 | 7.9 |
| Operating Margin | 42.12% | 48.77% | 44.23% | 10.12% | -21.38% | 12.65% | -15.3% | -11.38% | -10.99% | 3.46% | 0.1% | 0.96% | 3.22% | 7.27% |
| Earnings before Tax (EBT) | 142.6 | 196.1 | 217.1 | 27.17 | -18.32 | -0.3732 | - | - | - | - | - | - | - | - |
| Net income 1 | 92.76 | 163.7 | 165.5 | 25.15 | -11.07 | 2.586 | 2.052 | -2.54 | -4.677 | 5.612 | 2.2 | 2.5 | 4.3 | 8.2 |
| Net margin | 30.38% | 39.92% | 36.65% | 19.59% | -7.34% | 2.11% | 2.28% | -2.99% | -5.09% | 5.58% | 2.29% | 2.65% | 4.2% | 7.55% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 2/17/22 | 5/13/22 | 8/12/22 | 11/11/22 | 2/17/23 | 5/15/23 | 8/11/23 | 11/10/23 | 2/16/24 | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 45.9 | 226 | 314 | 403 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | 23,076 | 209,129 | 272,368 | 255,746 | - | - | - |
| ROE (net income / shareholders' equity) | 19% | 126% | 62.1% | 16.1% | - | 3.05% | 4.6% |
| ROA (Net income/ Total Assets) | 14.9% | 78% | 41.5% | 12.6% | - | - | - |
| Assets 1 | 179.5 | 644 | 1,292 | 1,440 | - | - | - |
| Book Value Per Share 2 | 2,935 | 12,414 | 41,605 | 23,081 | - | 19,301 | 19,528 |
| Cash Flow per Share | 522.0 | 7,371 | 12,851 | 6,281 | - | - | - |
| Capex | 4.07 | 174 | 61.7 | 63.3 | - | - | - |
| Capex / Sales | 3.33% | 15.47% | 4.5% | 7.41% | - | - | - |
| Announcement Date | 2/26/20 | 2/18/21 | 2/17/22 | 2/17/23 | 2/16/24 | - | - |
1KRW in Billions2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.37% | 733M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -37.00% | 391M | |
| -46.94% | 377M | |
| +13.32% | 332M |
- Stock Market
- Equities
- A096530 Stock
- Financials Seegene, Inc.
